Literature DB >> 22542308

Does the use of recombinant factor VIIA reduce morbidity or mortality in nonhemophiliac patients?

Steven Sattler1, Adam Schwartz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22542308     DOI： 10.1016/j.annemergmed.2012.02.027

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN： 0196-0644            Impact factor:   5.721


× No keyword cloud information.
  2 in total

1.  The Effect of Intravenous Administration of Active Recombinant Factor VII on Postoperative Bleeding in Cardiac Valve Reoperations; A Randomized Clinical Trial.

Authors:  Narges Payani; Mahnoosh Foroughi; Ali Dabbagh
Journal:  Anesth Pain Med       Date:  2015-02-01

2.  Use of Low-Dose Recombinant Factor Ⅶa for Uncontrolled Perioperative Bleeding.

Authors:  Zhi-Gang Chang; Xin Chu; Wen Chen; Jun-Hua Hu; Ji-Wu Gong; Da-Dong Liu; Qing He; Zhe Feng; Shi-Rou Xiao; Ya-Lin Liu
Journal:  Dose Response       Date:  2020-11-23       Impact factor: 2.658
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.